Suspension of trading
Centessa Pharmaceuticals plc Share Price
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.49B 5.06B 4.68B 8.88B 599B 9.04B 60.71B 23.62B 294B 23.53B 23.02B 1,019B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.33B 4.92B 4.55B 8.63B 582B 8.79B 59B 22.96B 285B 22.87B 22.37B 990B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 1 month | +2.22% | ||
| 3 months | +2.40% | ||
| 6 months | +78.49% | ||
| Current year | +61.94% |
| 1 month | 39.58 | 40.56 | |
| Current year | 21.5 | 40.56 | |
| 1 year | 13.67 | 40.56 | |
| 3 years | 5.15 | 40.56 | |
| 5 years | 2.88 | 40.56 | |
| 10 years | 2.88 | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2024 |
David Chao
ADM | Chief Administrative Officer | 58 | 31/03/2021 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 28/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 23/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 23/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-23 | Issuer sale | Director | -392,474 | 0.2537% | ||
| 06-23 | Issuer sale | Director | -248,570 | 0.1606% | ||
| 06-23 | Issuer sale | Director | -232,000 | 0.1499% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.80% | -.--% | +197.36% | +558.54% | 6.27B | ||
| -0.24% | +4.98% | +2.69% | +9.14% | 49.74B | ||
| -0.36% | +1.33% | +417.51% | +619.10% | 40.49B | ||
| -2.29% | +5.93% | +25.27% | +59.26% | 34.35B | ||
| -2.13% | +5.47% | +25.45% | -6.01% | 34.75B | ||
| -0.79% | +2.02% | +3.83% | +36.42% | 26.98B | ||
| +3.82% | +3.92% | - | - | 16.58B | ||
| -2.62% | +0.45% | +66.82% | +125.87% | 15.6B | ||
| -2.17% | +6.52% | +102.15% | +102.15% | 14.27B | ||
| -2.70% | -2.19% | +11.25% | +18.19% | 13.76B | ||
| Average | -0.87% | +3.78% | +94.70% | +169.18% | 25.28B | |
| Weighted average by Cap. | -0.95% | +4.30% | +96.46% | +150.30% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.14 12.12 11.2 21.26 1.43K 21.64 145.31 56.54 702.72 56.32 55.09 2.44K |
| Net income | -236M -206M -191M -176M -334M -22.53B -340M -2.28B -889M -11.04B -885M -866M -38.33B | -198M -173M -160M -148M -280M -18.87B -285M -1.91B -745M -9.25B -742M -725M -32.11B |
| Net Debt | -364M -319M -294M -272M -516M -34.81B -526M -3.53B -1.37B -17.07B -1.37B -1.34B -59.23B | -176M -154M -142M -132M -250M -16.83B -254M -1.71B -664M -8.25B -662M -647M -28.65B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
















